http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57108013-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_067cda10aaf6d4a5ca8180abe5a545c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b9036c33bbe3f4ea428655b76200f7c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 1980-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edc42ef78a039d0bf100f5af6020cb46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf77e099035d6824db05e4700831a7b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5fd5882c1a9b00e554c1a787eeb51c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06dc84c219e66930d2dbea5128a04f8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef2b62ca61c899766c9667d34e8c4cf2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30daf9cc9c555fa02dc1d373df0ee9a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9de13e653b306dfcb9a2312f5a1a16e6
publicationDate 1982-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S57108013-A
titleOfInvention Antibacterial agent
abstract PURPOSE: To provide an antibacterial agent having remarkable effect esp. to Mycobacterium tuberculosis and high safety, by using a specific 2,2'-dithiobisbenzamide derivative as an active component. n CONSTITUTION: An antibacterial agent containing the compound of formula[R 1 is (substituted) 1W15C alkylamino, 2W10C dialkylamino, (substituted) phenylamino, etc.; R 2 is H or halogen]as active component. The compound has strong antibacterial activity esp. to Mycobacterium tuberculosis, and since it has extremely high LD 50 , it can be administered at a considerably high dose. Applied in the form of tablet, powder, capsule, injection etc. Minimum effective dose: 500W1,000mg per dose for adult. n COPYRIGHT: (C)1982,JPO&Japio
priorityDate 1980-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1773
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415749735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227614740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72552

Total number of triples: 30.